You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SARS-CoV-2, Standard Risk

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe COVID-19 Trial in Thessaloniki (Coronavirus-2-specific T cells, standard of care (SOC))

Recruiting
  • Severe COVID-19
  • Coronavirus-2-specific T cells
  • standard of care (SOC)
  • Thessaloniki, Greece
  • +1 more
Nov 22, 2022

Corona Virus Infection, SARS-CoV-2 Infection, SARS-CoV-2 PCR Test Positive Trial in Germany (biological, drug, other)

Completed
  • Corona Virus Infection
  • +3 more
  • Convalescent plasma
  • +3 more
  • Freiburg im Breisgau, Baden-Württemberg, Germany
  • +5 more
Feb 9, 2022

SARS-CoV-2 Virus Trial in Bangkok (SARS-CoV-2 RNA detection)

Completed
  • SARS-CoV-2 Virus
  • SARS-CoV-2 RNA detection
  • Bangkok, Thailand
    2 Division of Nephrology,Department of Medicine Pramongkutklao H
Aug 31, 2023

COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

Completed
  • Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
    • Worthing, United Kingdom
      Dr Luke Hodgson
    Jul 15, 2022

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Recombinant SARS-CoV-2 vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • +2 more
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023

    End-stage Renal Disease, SARS-CoV-2 Acute Respiratory Disease, Dialysis; Complications Trial (Offering SARS-CoV-2 test)

    Not yet recruiting
    • End-stage Renal Disease
    • +2 more
    • Offering SARS-CoV-2 test
    • (no location specified)
    Dec 12, 2022

    Zinc Deficiency, Sars-CoV-2 Infection Trial in Barcelona (Zinc Acetate)

    Completed
    • Zinc Deficiency
    • Sars-CoV-2 Infection
    • Zinc Acetate
    • Barcelona, Spain
      Hospital del Mar
    Mar 18, 2023

    Covid19, COVID-19 Prevention Trial in Chandigarh (Hydroxychloroquine (HCQ), Standard care, Placebo)

    Recruiting
    • Covid19
    • COVID-19 Prevention
    • Hydroxychloroquine (HCQ)
    • +2 more
    • Chandigarh, India
      Post Graduate Institute of Medical Education and Research
    Jun 8, 2021

    SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +4 more
    • Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
    • +2 more
    • Shanghai, Shanghai, China
      Shanghai Municipal Center for Disease Control and Prevention
    Jul 17, 2023

    SARS-CoV-2 Trial in Nanjing (SARS-CoV-2 Bivalent mRNA Vaccine, Saline)

    Not yet recruiting
    • SARS-CoV-2
    • SARS-CoV-2 Bivalent mRNA Vaccine
    • Saline
    • Nanjing, Jiangsu, China
      Jiangsu Provincial Center for Disease Control and Prevention
    Jul 7, 2023

    SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

    Recruiting
    • SARS-CoV2 Infection
    • General SARS-CoV-2 Communication
    • Rural-Targeted SARS-CoV-2 Communication
    • Flint, Michigan
      Flint Journal Building
    Oct 10, 2023

    COVID-19 Trial in Chicago (Experimental: Primary Cohort, Placebo Comparator: Primary Cohort - Placebo)

    Active, not recruiting
    • COVID-19
    • Experimental: Primary Cohort
    • Placebo Comparator: Primary Cohort - Placebo
    • Chicago, Illinois
      University of Chicago
    Aug 24, 2023

    SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

    Active, not recruiting
    • SARS-CoV-2
    • SARS-CoV-2 mRNA vaccine (RBMRNA)
    • CoronaVac®
    • Chengdu, Sichuan, China
      Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
    Jun 12, 2023

    SARS-CoV-2 Infection Trial in Daejeon (CT-P59, Placebo)

    Completed
    Has Results
    • SARS-CoV-2 Infection
    • CT-P59
    • Placebo
    • Daejeon, Jung-gu, Korea, Republic of
      Chungnam National University Hospital
    Jun 27, 2022

    LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

    Not yet recruiting
    • SARS-CoV-2
    • +4 more
    • LumiraDx SARS-CoV-2 Ag Ultra
    • LumiraDx SARS-CoV-2 & Flu A/B
    • DeLand, Florida
      Hillcrest Medical Research
    Feb 6, 2023

    COVID-19 Patients - The Coronavirus Related Outpatient Work

    Completed
    • Covid-19 (SARS-CoV-2)
      • New Hyde Park, New York
        410 Lakeville Road, Suite 107
      Jul 13, 2022

      COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

      Not yet recruiting
      • COVID-19
      • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
      • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
      • (no location specified)
      Aug 4, 2023

      SARS-CoV-2 Vaccination on Cancer Patients Infected With

      Recruiting
      • COVID-19 Infection
      • COVID-19 Vaccine
      • no intervention
      • Beijing, Beijing, China
        Sanhuan Cancer Hospital, Chaoyang District, Beijing(Cancer Hospi
      Mar 7, 2023

      SARS-CoV-2 Trial in Islamabad (SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021), 0.9% sodium chloride solution)

      Recruiting
      • SARS-CoV-2
      • SARS-CoV-2 Bivalent mRNA vaccine (LVRNA021)
      • 0.9% sodium chloride solution
      • Islamabad, Pakistan
        Sindh Infectious Diseases Hospital & Research Center Dow Univers
      Apr 16, 2023

      COVID-19 Trial in New York (Hydroxychloroquine (HCQ))

      Completed
      Has Results
      • COVID-19
      • Hydroxychloroquine (HCQ)
      • New York, New York
        NYU Langone Health
      Dec 12, 2022

      COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

      Recruiting
      • COVID-19
      • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
      • Guangzhou, Guangzhou, China
        The Fifth Affiliated Hospital of Guangzhou Medical University
      Jan 28, 2023

      SARS-CoV-2 Infection Among Healthcare Workers

      Recruiting
      • COVID-19
      • inactivated COVID-19 vaccines; orally aerosolized Ad5-nCoV
      • Nanjing, Jiangsu, China
        The Affiliated Nanjing Drum Tower Hospital of Nanjing University
      Jan 10, 2023

      Severe Exacerbation of Severe Acute Respiratory Syndrome

      Active, not recruiting
      • SARS-CoV-2
        • Tokyo, Japan
          CMIC Co. Ltd.,
        Jun 5, 2023

        COVID-19 Transmission and Morbidity in Malawi

        Recruiting
        • SARS CoV 2 Infection
        • SARS CoV 2 Vaccination
          • Boston, Massachusetts
          • +1 more
          Aug 6, 2023

          SARS-CoV-2 Trial in Los Angeles (Family Risk Messaging, Personal Risk Messaging, Loss Protection)

          Enrolling by invitation
          • SARS-CoV-2
          • Family Risk Messaging
          • +3 more
          • Los Angeles, California
            AltaMed Health
          Jul 12, 2022